Amgen Announces Launch Of KYPROLIS® (carfilzomib) CENTRAL, An Online News Resource Demonstrating The Impact Of Relapsed Multiple Myeloma On The Lives Of Patients And Caregivers Read more about Amgen Announces Launch Of KYPROLIS® (carfilzomib) CENTRAL, An Online News Resource Demonstrating The Impact Of Relapsed Multiple Myeloma On The Lives Of Patients And Caregivers
Amgen To Present At The Goldman Sachs 37th Annual Global Healthcare Conference Read more about Amgen To Present At The Goldman Sachs 37th Annual Global Healthcare Conference
Amgen Receives Positive CHMP Opinion To Extend Indication Of Kyprolis® (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Read more about Amgen Receives Positive CHMP Opinion To Extend Indication Of Kyprolis® (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma
Kyprolis® (Carfilzomib) Demonstrates Economic Value In Relapsed Or Refractory Multiple Myeloma Manuscript Published In "Journal of Medical Economics" Read more about Kyprolis® (Carfilzomib) Demonstrates Economic Value In Relapsed Or Refractory Multiple Myeloma Manuscript Published In "Journal of Medical Economics"
Amgen Announces Early Tender Results Of Senior Notes Exchange Offers Read more about Amgen Announces Early Tender Results Of Senior Notes Exchange Offers
Amgen Announces Pricing Terms Of Senior Notes Exchange Offers Read more about Amgen Announces Pricing Terms Of Senior Notes Exchange Offers
Amgen Announces Voting Results of Annual Meeting of Stockholders Read more about Amgen Announces Voting Results of Annual Meeting of Stockholders
Amgen Highlights Data To Be Presented At 21st Congress Of The European Hematology Association Read more about Amgen Highlights Data To Be Presented At 21st Congress Of The European Hematology Association
Landmark deCODE genetics Study Points to a New Mechanism that Affects Cholesterol Levels and The Risk of Heart Disease Read more about Landmark deCODE genetics Study Points to a New Mechanism that Affects Cholesterol Levels and The Risk of Heart Disease
Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights Into Treatment Options For Patients Read more about Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights Into Treatment Options For Patients
